COMP <GO>
MMM vs BSX // GROSS PROFIT MARGIN
3M Company (NYSE) VS. Boston Scientific Corporation (NYSE) • 15-METRIC TALLY: MMM 6
— BSX 8
▲ GROSS PROFIT MARGIN LEADER: BSX
LAST: $178.36 (+2.31%) • MKT CAP: $90.09B
gross-margins
39.90%
LAST: $44.32 (+5.57%) • MKT CAP: $60.84B
gross-margins
69.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMM VS. BSX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMM | BSX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 39.90% | 69.00% | -29.10 | BSX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 32.90% | 9.20% | +23.70 | MMM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.1x | 15.8x | +2.30 | BSX | /valuation <GO> |
| Free Cash Flow Yield | 1.52% | 5.91% | -4.39 | BSX | /fcf-yield <GO> |
| Operating Margin | 18.60% | 18.00% | +0.60 | MMM | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 14.00% | -1.00 | BSX | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 19.90% | -18.40 | BSX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.70% | 0.00% | +1.70 | MMM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.37 | 2.77 | +1.60 | MMM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | BSX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.3 | 39.8 | +16.50 | MMM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.99 | -0.08 | BSX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.2x | 18.5x | +7.70 | BSX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $90.09B | $60.84B | $29.25B | MMM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMM REV | BSX REV | MMM GROSS % | BSX GROSS % | MMM FCF | BSX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $24.95B | $20.07B | 39.9% | 69.0% | $1.40B | $3.66B |
| FY 2024 | $24.57B | $16.75B | 41.2% | 68.6% | $638.0M | $2.65B |
| FY 2023 | $24.61B | $14.24B | — | — | $5.57B | $1.86B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMM // BETA 0.91
BSX // BETA 0.99